About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: November 15, 2010
Warning Letter Summary thru Third Quarter 2010, Part 2 – the Qualitative Look
A few weeks back, I posted the third quarter numerical report on Warning Letters and Notice of Violation letters issued by the FDA's Division of Drug Marketing, Advertising and Communications (DDMAC). In that accounting, I reported that there were a … Continue reading
Posted in Uncategorized
1 Comment